Profile, cost and pattern of prescriptions for polymedicated patients in Catalonia, Spain

BMJ Open

Volumn 3, Issue 12, 2013, Pages

  Lizano Díez, Irene ^a   Modamio, Pilar ^a   López Calahorra, Pilar ^b   Lastra, Cecilia F ^a   Gilabert Perramon, Antoni ^b   Segú, Jose L ^a   Mariño, Eduardo L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b C Agy Hlth Technol Assess Res   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ENALAPRIL; FUROSEMIDE; HYPNOTIC SEDATIVE AGENT; LOSARTAN; METFORMIN; OMEPRAZOLE; PARACETAMOL; SEDATIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG ANALYSIS; DRUG COST; DRUG PACKAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; SPAIN; VERY ELDERLY; YOUNG ADULT;

EID: 84890825331     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003963     Document Type: Article

References (36)

1. Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract 2011;61:83-4.
2. Brager R, Sloand E. The spectrum of polypharmacy. Nurse Pract 2005;30:44-51.
3. Bushardt R, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging 2008;3:383-9.
4. Aronson JK. In defence of polypharmacy. Br J Clin Pharmacol 2004;57:119-20.
5. Bjerrum L, Rosholm JU, Hallas J, et al. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997;53:7-11.
6. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997;157:2205-10.
7. Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drugs and potential adverse drug interactions in elderly. Ann Emerg Med 2001;38:666-71.
8. Rollason V, Vot N. Reduction of polypharmacy in the elderly. A systematic review of the role of the pharmacist. Drugs Aging 2003;20:817-32.
9. Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract 2000;17:261-7.
10. Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002;55:809-17.
11. Anthierens S, Tansens A, Petrovis M, et al. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 2010;11:65-71.
12. Denneboom W, Dautzenberg MGH, Grol R, et al. Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel. Br J Gen Pract 2006;56:504-10.
13. Steinman MA. Polypharmacy and the balance of medication benefits and risks. Am J Geriatr Pharmacother 2007;5:314-16.
14. Programas de mejora en la atención a pacientes crónicos y polimedicados durante el año 2009 (Programs of improvement in the attention to chronic and polymedicated patients during the year 2009). Inf Ter Sist Nac Salud 2009;33:28. http://www.msc.es/en/biblioPublic/publicaciones/ recursos-propios/infMedic/docs/vol33-1nuevasIndAutorizadas2008.pdf (accessed 17 Dec 2012).
15. Aranaz-Andrés JM, Aibar C, Limón R, et al. A study of the prevalence of adverse events in primary healthcare in Spain. Eur J Public Health 2012;22:921-5.
16. Haider SI, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int J Clin Pharmacol Ther 2007;45:643-53.
17. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007;24:14-19.
18. Bradley F, Wagner AC, Elvey R, et al. Determinants of the uptake of medicines use review (MURs) by community pharmacies in England: a multi-method study. Health Policy 2008;88:258-68.
19. Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2009;8:63-72.
20. Dong L, Yan H, Wang D. Polypharmacy and its correlates in village health clinics across 10 provinces of Western China. J Epidemiol Community Health 2010;64:549-53.
21. Catalan Health Service (CatSalut). The Catalan health care model. Health care regions. http://www10.gencat.net/catsalut/eng/coneix-models.htm (accessed 17 Dec 2012).
22. Official statistics website of Catalonia (Idescat). Statistical yearbook of Catalonia. http://www.idescat.cat/pub/?id=aec&lang=en (accessed 17 Dec 2012).
23. Classification of medicines (ATC) and defined daily doses (DDD) 2010. Helsinki: National Agency for Medicines, 2010.
24. Hovstadius B, Astrand B, Persson U, et al. Acquisition cost of dispensed drugs in individuals with multiple medications - a register-based study in Sweden. Health Policy 2011;101:153-61.
25. Farmaindustria. The pharmaceutical market in Spain. April 2009; Bulletin 48. http://www.farmaindustria.es (accessed 15 Apr 2013).
26. Law 29/2006, of 26 July 2006, on guarantees and rational drug use of medicines and health products. BOE no.178, of 27-07-2006; pp. 28122-65. http://www.boe.es/boe/dias/2006/07/27/pdfs/A28122-28165.pdf (accessed 17 Dec 2012).
27. Royal Decree 1338/2006, of 21 November 2006, developing certain aspects of the article 93 of the Law 29/2006, in the frame of the system of reference prices. BOE no 279, of 22-11-2006; pp. 40884-90. http://www.boe.es/boe/dias/ 2006/11/22/pdfs/A40884-40890.pdf (accessed 17 Dec 2012).
28. Fernández-Liz E, Modamio P, Catalán A, et al. Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain. Br J Clin Pharmacol 2008;65: 407-17.
29. Clavenna A, Berti A, Gualandi L, et al. Drug utilisation profile in the Italian paediatric population. Eur J Ped 2009;168:173-81.
30. Jyrkkä J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009;26:493-503.
31. Kennerfalk A, Ruigómez A, Wallander MA, et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002;36:797-803.
32. Cafferata GL, Meyers SM. Pathways to psychotropic drugs. Understanding the basis of gender differences. Med Care 1990;28:285-300.
33. Simoni-Wastila L. Gender and psychotropic drug use. Med Care 1998;36:88-94.
34. Roe CM, McNamara AM, Motheral BR. Gender-and age-related prescription drug use patterns. Ann Pharmacother 2002;36:30-9.
35. Bertoldi AD, Barros AJD, Wagner A, et al. A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res 2008;8:222-30.
36. Moen J, Norrgård S, Antonov K, et al. GP's perceptions of multiple-medicine use in older patients. J Eval Clin Pract 2010;16:69-75.